Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies

This publication has 94 references indexed in Scilit:

• Common C677T Polymorphism of the Methylenetetrahydrofolate Reductase Gene and the Risk of Venous Thromboembolism: Meta-Analysis of 31 Studies
  Pathophysiology of Haemostasis and Thrombosis, 2002
• Age, sex and vitamin status affect plasma level of homocysteine, but hyperhomocysteinaemia is possibly not an important risk factor for venous thrombophilia in Taiwanese Chinese
  British Journal of Haematology, 2002
• Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism
  The Hematology Journal, 2001
• Prevalence of Methylenetetrahydrofolate Reductase Mutations in Patients With Venous Thrombosis
  Molecular Diagnosis, 2000
• Thrombophilic predisposition in stroke and venous thromboembolism in Danish
  Blood Coagulation & Fibrinolysis, 1999
• A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease
  British Journal of Haematology, 1999
• Risk of venous thrombosis in carriers of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase*
  Molecular Diagnosis, 1997
• Plasma Homocysteine Levels in Patients With Deep Venous Thrombosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994